Abstract | BACKGROUND: MATERIALS AND METHODS: Colon (HCT-116) and hepatic (HepG2) tumor cells were treated with varying concentrations of BCAA with or without fluorouracil (5-FU). The effect of BCAA on insulin-initiated proliferation was determined. Gene and protein expression was analyzed by quantitative real-time polymerase chain reaction (qRT-PCR) and western blotting, respectively. RESULTS: BCAA supplementation had no significant effect on cell proliferation and did not show significant synergistic or antagonistic effects with 5-FU. However, BCAA significantly decreased insulin-initiated proliferation of human colon and hepatic cancer cell lines in vitro. BCAA supplementation caused a marked decrease in activated IGF-IR expression and significantly enhanced both mRNA and protein expression of LC3-II and BECN1 (BECLIN-1). CONCLUSION: BCAA could be a useful chemopreventive modality for cancer in hyperinsulinemic conditions.
|
Authors | Gizachew Yismaw Wubetu, Tohru Utsunomiya, Daichi Ishikawa, Tetsuya Ikemoto, Shinichiro Yamada, Yuji Morine, Shuichi Iwahashi, Yu Saito, Yusuke Arakawa, Satoru Imura, Hideki Arimochi, Mitsuo Shimada |
Journal | Anticancer research
(Anticancer Res)
Vol. 34
Issue 9
Pg. 4789-96
(Sep 2014)
ISSN: 1791-7530 [Electronic] Greece |
PMID | 25202059
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved. |
Chemical References |
- Amino Acids, Branched-Chain
- Insulin
- Receptor, IGF Type 1
|
Topics |
- Amino Acids, Branched-Chain
(pharmacology)
- Apoptosis
(drug effects)
- Autophagy
(drug effects)
- Cell Line, Tumor
- Cell Proliferation
(drug effects)
- Dietary Supplements
- HCT116 Cells
- Hep G2 Cells
- Humans
- Insulin
(pharmacology)
- Phosphorylation
(drug effects)
- Receptor, IGF Type 1
(metabolism)
|